|
Calcitriol Injection
» Calcitriol Injection is a sterile solution of Calcitriol. It contains an amount of Calcitriol equivalent to not less than 90.0 percent and not more than 115.0 percent of the labeled amount of calcitriol (C27H44O3). It contains no antimicrobial agents.
Packaging and storage
Preserve in single-dose containers, preferably of Type I glass, protected from light. Store at controlled room temperature.
Identification
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Bacterial endotoxins
pH
Particulate matter
Other requirements
It meets the requirements under Injections
Assay
[noteAvoid unnecessary exposure of solutions to light or air. ]
Mobile phase
Prepare a filtered and degassed mixture of methanol and water (74:26). Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Transfer 3.0 mL of USP Calcitriol Solution RS, equilibrated to room temperature, to a container; add 3.0 mL of water; and mix.
Assay preparation
Transfer an accurately measured volume of Injection, equivalent to about 3 µg of calcitriol, to a container; add a sufficient amount of water to dilute to a total volume of 3.0 mL; add 3.0 mL of methanol; and mix.
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 100 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in µg, of calcitriol (C27H44O3) in each mL of the Injection taken by the formula:
C(rU / rS)
in which C is the concentration, in µg per mL, of calcitriol in the USP Calcitriol Solution RS; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2433
Pharmacopeial Forum: Volume No. 32(1) Page 61
|